Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development
- PMID: 10518221
- DOI: 10.1016/s1097-2765(00)80342-1
Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development
Abstract
Ephrin-B2 is a transmembrane ligand that is specifically expressed on arteries but not veins and that is essential for cardiovascular development. However, ephrin-B2 is also expressed in nonvascular tissues and interacts with multiple EphB class receptors expressed in both endothelial and nonendothelial cell types. Thus, the identity of the relevant receptor for ephrin-B2 and the site(s) where these molecules interact to control angiogenesis were not clear. Here we show that EphB4, a specific receptor for ephrin-B2, is exclusively expressed by vascular endothelial cells in embryos and is preferentially expressed on veins. A targeted mutation in EphB4 essentially phenocopies the mutation in ephrin-B2. These data indicate that ephrin-B2-EphB4 interactions are intrinsically required in vascular endothelial cells and are consistent with the idea that they mediate bidirectional signaling essential for angiogenesis.
Similar articles
-
Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis.Genes Dev. 1999 Feb 1;13(3):295-306. doi: 10.1101/gad.13.3.295. Genes Dev. 1999. PMID: 9990854 Free PMC article.
-
Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4.Cell. 1998 May 29;93(5):741-53. doi: 10.1016/s0092-8674(00)81436-1. Cell. 1998. PMID: 9630219
-
Stromal cells expressing ephrin-B2 promote the growth and sprouting of ephrin-B2(+) endothelial cells.Blood. 2001 Aug 15;98(4):1028-37. doi: 10.1182/blood.v98.4.1028. Blood. 2001. PMID: 11493448
-
Regulation of signaling interactions and receptor endocytosis in growing blood vessels.Cell Adh Migr. 2014;8(4):366-77. doi: 10.4161/19336918.2014.970010. Cell Adh Migr. 2014. PMID: 25482636 Free PMC article. Review.
-
Molecular identity of arteries, veins, and lymphatics.J Vasc Surg. 2019 Jan;69(1):253-262. doi: 10.1016/j.jvs.2018.06.195. Epub 2018 Aug 25. J Vasc Surg. 2019. PMID: 30154011 Free PMC article. Review.
Cited by
-
Recent advances of the Ephrin and Eph family in cardiovascular development and pathologies.iScience. 2024 Jul 19;27(8):110556. doi: 10.1016/j.isci.2024.110556. eCollection 2024 Aug 16. iScience. 2024. PMID: 39188984 Free PMC article. Review.
-
Improved efficacy of pembrolizumab combined with soluble EphB4-albumin in HPV-negative EphrinB2 positive head neck squamous cell carcinoma.Oncotarget. 2024 Jul 10;15:444-458. doi: 10.18632/oncotarget.28605. Oncotarget. 2024. PMID: 38985143 Free PMC article. Clinical Trial.
-
Eph-ephrin signaling couples endothelial cell sorting and arterial specification.Nat Commun. 2024 Apr 3;15(1):2539. doi: 10.1038/s41467-024-46300-0. Nat Commun. 2024. PMID: 38570531 Free PMC article.
-
Update on the Vein of Galen Aneurysmal Malformation : Disease Concept and Genetics.J Korean Neurosurg Soc. 2024 May;67(3):308-314. doi: 10.3340/jkns.2024.0058. Epub 2024 Mar 20. J Korean Neurosurg Soc. 2024. PMID: 38504516 Free PMC article.
-
Targeting EphA2: a promising strategy to overcome chemoresistance and drug resistance in cancer.J Mol Med (Berl). 2024 Apr;102(4):479-493. doi: 10.1007/s00109-024-02431-x. Epub 2024 Feb 23. J Mol Med (Berl). 2024. PMID: 38393661 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous